Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-01-08 @ 7:12 PM
Study NCT ID:
NCT00626405
Status:
COMPLETED
Last Update Posted:
2018-05-01
First Post:
2008-02-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-28
First Submit QC Date:
None
Study First Post Date:
2008-02-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-01
Results First Submit QC Date:
None
Results First Post Date:
2018-05-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-30
Last Update Post Date:
2018-05-01
Last Update Post Date Type:
ACTUAL